• Home
  • Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?

Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?

Author List
Derkay CS, Wikner EE, Pransky S, Best SR, Zur K, Sidell DR, Klein A, Rosen C, Dikkers FG, Johnson R
Publication
The Laryngoscope
Publication ID (Profile URL)
https://researcherprofiles.org/profile/293872779
Publication Year
2022
PubMed ID
35543118
Publication Title
Derkay CS, Wikner EE, Pransky S, Best SR, Zur K, Sidell DR, Klein A, Rosen C, Dikkers FG, Johnson R. Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why? Laryngoscope. 2023 01; 133(1):2-3.